Shockwave Medical Launches Enhanced E8 Catheter
Shockwave Medical, Inc. is excited to unveil the Shockwave E8 Peripheral Intravenous Lithotripsy (IVL) Catheter, a significant advancement in the battle against peripheral arterial disease (PAD). Recently approved by the U.S. Food and Drug Administration (FDA), this catheter represents a critical breakthrough for physicians dealing with difficult vascular health conditions.
What is Peripheral Arterial Disease?
PAD affects more than eight million adults across the United States, especially those aged 40 and older. This condition can drastically lower quality of life and heightens the risk of serious cardiovascular incidents like heart attacks and strokes. Among the worst types of PAD is chronic limb-threatening ischemia (CLTI), which places nearly two million patients at risk each year. CLTI carries severe consequences, including high rates of major amputations and greater mortality risks than many types of cancer.
Key Features of the Shockwave E8 Catheter
The Shockwave E8 Catheter is specifically designed to improve treatment for calcified lesions located in the femoro-popliteal region and below the knee. With its advanced IVL technology, it delivers 400 pulses per second across eight emitters located on an 80cm balloon. This setup allows for targeted treatment of longer lesions, enhancing the catheter’s working length to 150cm and enabling healthcare providers to access previously hard-to-reach areas.
Advantages for Both Doctors and Patients
Dr. Venita Chandra, a vascular surgeon and clinical professor at Stanford Health Care, notes that this innovative catheter greatly enhances treatment for patients with complex calcified conditions. Its capability to manage lengthy lesions and navigate intricate anatomical variations equips physicians with the necessary tools to address particularly tough cases, such as those relating to CLTI.
A Complete IVL Portfolio
With the introduction of the Shockwave E8 into its range of IVL solutions—which also includes the Shockwave L6, Shockwave M5+, and Shockwave S4 catheters—Shockwave Medical now offers physicians a comprehensive portfolio to tackle the various challenges associated with treating calcified peripheral artery lesions.
Dedication to Innovation
Isaac Zacharias, President of Shockwave Medical, shared his excitement about the positive responses from doctors who have trialed the E8 catheter. Shockwave Medical's commitment to innovation directed by physician input and effective solutions shines through with the introduction of this catheter, which is set to become a preferred tool for treating PAD.
About Shockwave Medical
Shockwave Medical, a part of Johnson & Johnson MedTech, is at the leading edge of innovative cardiovascular treatments. Their pioneering Intravascular Lithotripsy technology utilizes sonic pressure waves, revolutionizing the way atherosclerotic cardiovascular disease is treated. This approach is geared towards significantly enhancing patient outcomes.
About Johnson & Johnson
Johnson & Johnson is committed to improving global health through pioneering medical solutions. Their investment in research and development focuses on creating less invasive treatments, fostering innovation in varied fields including cardiovascular health, orthopaedics, and vision.
Frequently Asked Questions
What is the Shockwave E8 Catheter used for?
The Shockwave E8 Catheter is designed to treat patients suffering from calcified peripheral artery disease, especially in complex cases like chronic limb-threatening ischemia.
What distinguishes the E8 Catheter from others?
The E8 Catheter boasts advanced features such as a longer working length and enhanced pulse delivery, which help improve treatment for longer lesions.
How prevalent is PAD among patients?
More than eight million individuals in the United States are affected by peripheral artery disease, primarily those over the age of 40.
What type of technology does Shockwave Medical implement?
Shockwave Medical utilizes Intravascular Lithotripsy technology, which uses sonic pressure waves to break up calcified plaque in arteries.
Where can I find additional information about Shockwave Medical?
You can find more details on Shockwave Medical's official website.
